{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:29:24Z","timestamp":1648639764273},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.cancergencyto.2004.01.002","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:27:57Z","timestamp":1095186477000},"page":"165-169","source":"Crossref","is-referenced-by-count":2,"title":["Genotyping of AR and PSA polymorphisms in a patient with Klinefelter syndrome, non-Hodgkin lymphoma, and adenocarcinoma of the prostate"],"prefix":"10.1016","volume":"153","author":[{"given":"Rodrigo","family":"Mattos dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Aparecida Rainho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Carlos Souza Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Carlos Souza Trindade Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Lauro Viana de Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Regina Rogatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/2477","article-title":"Evidence for a prostate cancer susceptibility locus on the X chromosome","volume":"20","author":"Xu","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB2","first-page":"4013","article-title":"Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX","volume":"5","author":"Lange","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.pcan.4500422","article-title":"Androgens and growth factors in prostate cancer: a transgenic perspective","volume":"3","author":"Greenberg","year":"2000","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB4","first-page":"4497","article-title":"Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility","volume":"58","author":"Ross","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB5","first-page":"985","article-title":"Is the androgen receptor CAG repeats length significant for prostate cancer?","volume":"11","author":"Giovannucci","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB6","first-page":"65","article-title":"Identification of a polymorphism in the ARE1 region of the PSA promoter","volume":"40","author":"Rao","year":"1999","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB7","first-page":"839","article-title":"Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci","volume":"60","author":"Xue","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB8","series-title":"Human chromosomes: principles and techniques","first-page":"362","article-title":"Chromosomes in clinical medicine","author":"Verma","year":"1995"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB9","series-title":"Smith's recognizable patters of human malformation","author":"Jones","year":"1997"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.1995.85","article-title":"Cancer incidence in men with Klinefelter syndrome","volume":"71","author":"Hasle","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1469-1809.2001.6520177.x","article-title":"Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study","volume":"65","author":"Swerdlow","year":"2001","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0009-9120(99)00023-5","article-title":"Rapid and accurate determination of (CAG) repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis","volume":"32","author":"Bharaj","year":"1999","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB13","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/ar118","article-title":"The role of X-chromosome inactivation in female predisposition to autoimmunity","volume":"2","author":"Chitnis","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1034\/j.1399-0004.2000.580504.x","article-title":"The causes and consequences of random and non-random X chromosome inactivation in humans","volume":"58","author":"Brown","year":"2000","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(80)91539-1","article-title":"Klinefelter syndrome: predisposition to acute non-lymphocytic leukemia?","volume":"1","author":"Geraedts","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0021-9258(18)52466-2","article-title":"Transcriptional activation and nuclear targeting signals of the human androgen receptor","volume":"266","author":"Simental","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB19","first-page":"1937","article-title":"The CAG and GGC microssatellites of androgen receptor gene are in linkage disequilibrium in men with prostate cancer","volume":"55","author":"Irvine","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB20","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","article-title":"The length and location of CAG trinucleotide repeat in androgen receptor N-terminal domain affect transactivation function","volume":"22","author":"Chamberlain","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2004.01.002_BIB21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/carcin\/23.10.1647","article-title":"Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk","volume":"23","author":"Gsur","year":"2002","journal-title":"Carcinogenesis"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460804000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460804000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T18:01:07Z","timestamp":1624644067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460804000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0165460804000214"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2004.01.002","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}